Quantitative analysis validation for sclerotherapy treatment of lower limb telangiectasias.

[1]  P. Kolh,et al.  European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. , 2022, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[2]  C. Padovani,et al.  Polidocanol Plus Glucose Versus Glucose Alone for the Treatment of Telangiectasias: Triple Blind, Randomised Controlled Trial (PG3T). , 2020, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[3]  W. Marston,et al.  CEAP classification system and reporting standard, revision 2020. , 2020, Journal of vascular surgery. Venous and lymphatic disorders.

[4]  Elena De Momi,et al.  Blood vessel segmentation algorithms - Review of methods, datasets and evaluation metrics , 2018, Comput. Methods Programs Biomed..

[5]  C. Padovani,et al.  Sclerotherapy for Reticular Veins in the Lower Limbs: A Triple-Blind Randomized Clinical Trial , 2017, JAMA dermatology.

[6]  Andrzej Materka,et al.  Simulation of MR angiography imaging for validation of cerebral arteries segmentation algorithms , 2016, Comput. Methods Programs Biomed..

[7]  Matheus Bertanha,et al.  Polidocanol versus glucose in the treatment of telangiectasia of the lower limbs (PG3T) , 2016, Medicine.

[8]  Pascal Fua,et al.  Simultaneous segmentation and anatomical labeling of the cerebral vasculature , 2016, Medical Image Anal..

[9]  L. Thomson.  Sclerotherapy of telangiectasias or spider veins in the lower limb: A review. , 2016, Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing.

[10]  Lei Wang,et al.  Active Contours Driven by Multi-Feature Gaussian Distribution Fitting Energy with Application to Vessel Segmentation , 2015, PloS one.

[11]  Gábor Székely,et al.  Reconstructing cerebrovascular networks under local physiological constraints by integer programming , 2015, Medical Image Anal..

[12]  Gözde B. Ünal,et al.  A Higher-Order Tensor Vessel Tractography for Segmentation of Vascular Structures , 2015, IEEE Transactions on Medical Imaging.

[13]  Yadong Wang,et al.  Accurate Vessel Segmentation With Constrained B-Snake , 2015, IEEE Transactions on Image Processing.

[14]  Yalin Zheng,et al.  Retinal Vessel Segmentation: An Efficient Graph Cut Approach with Retinex and Local Phase , 2015, PloS one.

[15]  Ke Chen,et al.  Automated Vessel Segmentation Using Infinite Perimeter Active Contour Model with Hybrid Region Information with Application to Retinal Images , 2015, IEEE Transactions on Medical Imaging.

[16]  Matheus Bertanha,et al.  Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial , 2014, Trials.

[17]  Yun Tian,et al.  A Vessel Active Contour Model for Vascular Segmentation , 2014, BioMed research international.

[18]  Salah Bourennane,et al.  Bayesian Method with Spatial Constraint for Retinal Vessel Segmentation , 2013, Comput. Math. Methods Medicine.

[19]  I. Bihari,et al.  Venous symptoms in C0 and C1 patients: UIP consensus document. , 2013, International angiology : a journal of the International Union of Angiology.

[20]  A. Davies,et al.  Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review , 2013 .

[21]  M. Goldman,et al.  Treatment of Reticular and Telangiectatic Leg Veins: Double‐Blind, Prospective Comparative Trial of Polidocanol and Hypertonic Saline , 2012, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[22]  Z. Jing,et al.  Efficacy and safety of Aethoxysklerol® (polidocanol) 0.5%, 1% and 3% in comparison with placebo solution for the treatment of varicose veins of the lower extremities in Chinese patients (ESA-China Study) , 2012, Phlebology.

[23]  Stephane Cotin,et al.  Robust RANSAC-based blood vessel segmentation , 2012, Medical Imaging.

[24]  L. Mazzolai,et al.  A Double‐Blind, Randomized Study Comparing Pure Chromated Glycerin with Chromated Glycerin with 1% Lidocaine and Epinephrine for Sclerotherapy of Telangiectasias and Reticular Veins , 2011, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[25]  C. Pannucci,et al.  Identifying and Avoiding Bias in Research , 2010, Plastic and reconstructive surgery.

[26]  E. Rabe,et al.  Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study) , 2010, Phlebology.

[27]  Ming Liu,et al.  Active contours driven by local Gaussian distribution fitting energy , 2009, Signal Process..

[28]  Mitchel P Goldman,et al.  Efficacy of Graduated Compression Stockings for an Additional 3 Weeks after Sclerotherapy Treatment of Reticular and Telangiectatic Leg Veins , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[29]  Max W. K. Law,et al.  Weighted Local Variance-Based Edge Detection and Its Application to Vascular Segmentation in Magnetic Resonance Angiography , 2007, IEEE Transactions on Medical Imaging.

[30]  D. Hayoz,et al.  Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study. , 2007, Journal of vascular surgery.

[31]  Anthony J Viera,et al.  Eliminating bias in randomized controlled trials: importance of allocation concealment and masking. , 2007, Family medicine.

[32]  D. Eckmann,et al.  Dose‐ and Time‐Dependent Liquid Sclerosant Effects on Endothelial Cell Death , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[33]  G. Moneta,et al.  Revision of the CEAP classification for chronic venous disorders: consensus statement. , 2004, Journal of vascular surgery.

[34]  D. Hayoz,et al.  Single‐Blind, Randomized Study Comparing Chromated Glycerin, Polidocanol Solution, and Polidocanol Foam for Treatment of Telangiectatic Leg Veins , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[35]  S. Zimmet.  Sclerotherapy treatment of telangiectasias and varicose veins. , 2003, Techniques in vascular and interventional radiology.

[36]  M. Goldman,et al.  Comparative Trial Between Sodium Tetradecyl Sulfate and Glycerin in the Treatment of Telangiectatic Leg Veins , 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[37]  M. Goldman.  Treatment of Varicose and Telangiectatic Leg Veins: Double‐Blind Prospective Comparative Trial Between Aethoxyskerol and Sotradecol , 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[38]  N. Spurrier,et al.  Sclerotherapy for leg telangiectasia--a blinded comparative trial of polidocanol and hypertonic saline. , 1999, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[39]  Guidelines,et al.  Guidelines of care for sclerotherapy treatment of varicose and telangiectatic leg veins , 1996 .

[40]  J. Ratz,et al.  Treatment of essential telangiectasia: effects of increasing concentrations of polidocanol. , 1989, Journal of the American Academy of Dermatology.

[41]  Andrew N. Nicolaides,et al.  Reporting standards in venous disease , 1988 .

[42]  J. Ratz,et al.  Treatment of telangiectasia: comparison of sclerosing agents. , 1987, The Journal of dermatologic surgery and oncology.

[43]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[44]  Y H Chan,et al.  Biostatistics 104: correlational analysis. , 2003, Singapore medical journal.